-- 
4SC Says Anti-Cancer Compound Resminostat Gets Positive Opinion

-- B y   M a r i a j o s e   V e r a
-- 
2011-10-13T05:34:02Z

-- http://www.bloomberg.com/news/2011-10-13/4sc-says-anti-cancer-compound-resminostat-gets-positive-opinion.html
4SC AG (VSC)  said its anti-cancer compound
Resminostat was designated by the European Medicines Agency as
orphan medicinal product for the treatment of Hodgkinâ€™s
Lymphoma.  To contact the editor responsible for this story:
Mariajose Vera at 
 mvera1@bloomberg.net  